Stay updated with breaking news from Nasdaq Agle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) from a sell rating to a hold rating in a research report report published on Saturday morning. Several other equities analysts have also recently weighed in on AGLE. Stifel Nicolaus assumed coverage on shares of Aeglea BioTherapeutics in a research note on Tuesday, July 25th. […]
Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE – Get Free Report) was the recipient of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 1,570,000 shares, a decrease of 26.3% from the July 31st total of 2,130,000 shares. Based on an average daily trading volume, of 6,290,000 […]
StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a research report sent to investors on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities research analysts have also issued reports on AGLE. Stifel Nicolaus started coverage on Aeglea BioTherapeutics in a report on […]
StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a research report report published on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. AGLE has been the subject of several other research reports. Wells Fargo & Company boosted their target price on shares of Aeglea BioTherapeutics […]
StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Free Report) in a research report released on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Stifel Nicolaus began coverage on Aeglea BioTherapeutics in a research note on Tuesday, July 25th. They set a buy rating and a $0.90 […]